![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
LONG-TERM EFFICACY AND SAFETY OF THE INTERFERON- AND RIBAVIRIN-FREE REGIMEN OF PARITAPREVIR/RITONAVIR AND OMBITASVIR IN HCV GENOTYPE 1B-INFECTED TREATMENT-EXPERIENCED JAPANESE PATIENTS
|
|
|
Reported by Jules Levin
APASL 2015
The 24th Conference of the Asian Pacific Association for the Study of the Liver, Istanbul, Turkey, 12-15 March 2015
Kazuaki Chayama, Kazuo Notsumata, Masayuki Kurosaki, Ken Sato, Lino Rodrigues-Jr, Carolyn Setze, Prajakta Badri, Tami Pilot-Matias, Regis A. Vilchez, Hiromitsu Kumada
![CROI1.gif](../images/031815/031815-3/CROI1.gif)
![CROI2.gif](../images/031815/031815-3/CROI2.gif)
![CROI3.gif](../images/031815/031815-3/CROI3.gif)
![CROI4.gif](../images/031815/031815-3/CROI4.gif)
![CROI5.gif](../images/031815/031815-3/CROI5.gif)
![CROI6.gif](../images/031815/031815-3/CROI6.gif)
![CROI7.gif](../images/031815/031815-3/CROI7.gif)
![CROI8.gif](../images/031815/031815-3/CROI8.gif)
![CROI9.gif](../images/031815/031815-3/CROI9.gif)
![CROI10.gif](../images/031815/031815-3/CROI10.gif)
![CROI11.gif](../images/031815/031815-3/CROI11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|